TPST insider buying
Every open-market purchase of Tempest Therapeutics, Inc. (TPST) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$1M
Insiders buying (12m)1
Purchases on record2
Last purchase filedJun 23, 2026
In the last 12 months, 1 insider of Tempest Therapeutics, Inc. bought $1M of TPST stock on the open market in 2 reported purchases. The most recent was filed on Jun 23, 2026: Angel Matthew (CEO and President, Director, 10% Owner) bought 231,482 shares at $2.16, worth $500K.
Get the next TPST insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram